MKRN1 and hydrops fetalis: Collectively, these findings demonstrate that FOXM1 is a novel regulator of mitochondrial homeostasis and cardiac function; targeting FOXM1/MKRN1/LKB1/AMPK axis might be a potential therapeutic option to protect against I/R injury and HF.